Skip to main content

Table 1 Demographic and clinical details of samples

From: The fecal microbiota of patients with pancreatic ductal adenocarcinoma and autoimmune pancreatitis characterized by metagenomic sequencing

Factor PDAC (n = 32) HC (n = 32) AIP (n = 32)
Age 59.31 ± 9.53 58.63 ± 10.28 58.83 ± 9.76
Gender (F/n) 21.87% (7) 18.75% (6) 18.75% (6)
BMI 23.21 ± 3.24 23.18 ± 3.07 24.37 ± 3.09
Hypertension (n) 34.38% (11) 25% (8) 6.25% (2)
Diabetes (n) 31.25% (10) 16% (5) 28.13% (9)
Jaundice (n) 25.00% (8) 0 (0) 0 (0)
Tumor location (n)
 Pancreatic head 40.63% (13)
 Pancreatic neck 12.50% (4)
 Pancreatic body 3.13% (1)
 Pancreatic tail 6.25% (2)
 Pancreatic head and body 12.50% (4)
 Pancreatic body and tail 25.00% (8)
TNS staging (n)
 I 37.50% (12)
 II 28.13% (9)
 III 18.75% (6)
 IV 15.63% (5)
CA-19–9 u/ml 137.10(15.54–379.60)
  1. Data are expressed as mean ± SD or median (1st-3st quartile) according to the normality of distribution. F: female, PDAC: pancreatic ductal adenocarcinoma, AIP: autoimmune pancreatitis, HC: healthy control